Abstracts by key term: Revvity
“We are the partner of the global research community”
When you talk to Marcus Quack, the DACH managing director of Revvity, and ask him what the company, which is only a few months old, actually does, he first has to take a deep breath. The company was previously affiliated with PerkinElmer, whose applied, food and enterprise services were purchased by private equity firm New Mountain Capital for nearly $2.5 billion. The new scientific solutions company Revvity, however, continues to support pharmaceutical and biotech companies as well as diagnostic laboratories, universities and governments under a new name. “Monitor Health Services Research” spoke to Marcus Quack about the company’s rather ambitious goals and a possible link to health services research.